[1] 郑荣寿,孙可欣,张思维. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志,2019,41(1):19-28. [2] Dekker E, Taniis PJ, Vleugels JLA, et al.Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480. [3] Leddin D, Lieberman DA, Tse F, et al.Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus[J]. Gastroenterology, 2018, 155(5): 1325-1347. [4] Benson AB, Venook AP, Al-Hawary MM, et al.NCCN Guidelines Insights: Colon Cancer, Version 2.2018[J]. J Natl Compr Canc Netw, 2018, 16(4): 359-369. [5] Monahan KJ, Bradshaw N, Dolwani S, et al.Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)[J]. Gut, 2020, 69(3): 411-444. [6] 李聪. 结直肠癌筛查现状[J]. 广东医学,2016,37(22):3328-3330. [7] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020,北京)[J]. 中华肿瘤杂志,2021,43(1):16-38. [8] 周迪,路明亮,蒋明茗. 胃癌早期诊断的研究[J]. 胃肠病学和肝病学杂志,2021,30(6):606-611. [9] Yao K, Uedo N, Kamada T, et al.Guidelines for endoscopic diagnosis of early gastric cancer[J]. Dig Endosc, 2020, 32(5): 663-698. [10] Jun JK, Choi KS, Lee HY, et al.Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality[J]. Gastroenterology, 2017, 152(6): 1319-1328. [11] 赵敏,褚以忞,彭海霞. 结直肠癌和结直肠腺瘤筛查方式的研究进展[J]. 上海交通大学学报(医学版),2022,42(5):673-679. [12] 王亚军,杨幼林. 结肠镜检查不良事件及处理方法的临床研究进展[J]. 国际消化病杂志, 2019, 39(5): 325-328. [13] 李振东,张雪,何帅. 无痛胃镜联合结肠镜对胃肠道疾病安全性及有效性探讨[J]. 当代医学,2021,27(3):26-28. [14] 石菊芳,黄慧瑶,郭兰伟,等. 我国城市大肠癌高危人群对大肠腔镜筛查的接受度与支付意愿调查[J]. 中华预防医学杂志,2015,49(5):381-386. [15] Ladabaum U, Mannalithara A, Meester RGS, et al.Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years[J]. Gastroenterology, 2019, 157(1): 137-148. [16] Kahi CJ, Anderson JC, Rex DK.Screening and surveillance for colorectal cancer: state of the art[J]. Gastrointest Endosc, 2013, 77(3): 335-350. [17] Atkin W, Rogers P, Cardwell C, et al.Wide variation in adenoma detection rates at screening flexible sigmoidoscopy[J]. Gastroenterology, 2004, 126(5): 1247-1256. [18] Schoen RE, Pinsky PF, Weissfeld JL, et al.Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy[J]. N Engl J Med, 2012, 366(25): 2345-2357. [19] Shaukat A, Kahi CJ, Burke CA, et al.ACG Clinical Guidelines: Colorectal Cancer Screening 2021[J]. Am J Gastroenterol, 2021, 116(3): 458-479. [20] 霍文捷,李耀平. 结直肠癌筛查方法现状及研究进展[J]. 肿瘤研究与临床,2020,32(6):450-452. [21] Tinmouth J, Lansdorp-Vogelaar I, Allison JE.Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know[J]. Gut, 2015, 64(8): 1327-1337. [22] 陈宏达,卢明,刘成成,等. 结肠镜、免疫法粪便隐血试验和新型风险评估筛查方案在人群结直肠癌筛查中的参与率比较及其影响因素分析[J]. 中华流行病学杂志,2020, 41(10):1655-1661. [23] 李鹏,张澍田. 中国早期结直肠癌及癌前病变筛查与诊治共识[A]. 见:《第四届中西医消化健康论坛资料汇编2016年》[C].北京:2016. [24] Lin JS, Perdue LA, Henrikson NB, et al.Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force[J]. JAMA, 2021, 325(19): 1978-1998. [25] Atkin W, Dadswell E, Wooldrage K, et al.Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial[J]. Lancet, 2013, 381(9873): 1194-1202. [26] Smith RA, Cokkinides V, Brawley OW.Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening[J]. CA Cancer J Clin, 2009, 59(1): 27-41. [27] 马志刚,朱晓麟,马丽红,等. 基于多靶点粪便FIT-DNA联合检测技术的结直肠癌早期筛查结果分析[J]. 中华结直肠疾病电子杂志,2019,8(6):616-621. [28] Deenadayalu VP, Rex DK.Fecal-based DNA assays: a new, noninvasive approach to colorectal cancer screening[J]. Cleve Clin J Med, 2004, 71(6): 497-503. [29] Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14): 1287-1297. [30] Davidson KW, Barry MJ, Mangione CM, et al.Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement[J]. JAMA, 2021, 325(19): 1965-1977. [31] Wolf AMD, Fontham ETH, Church TR, et al.Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2018, 68(4): 250-281. [32] Provenzale D, Ness RM, Llor X, et al.NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020[J]. J Natl Compr Canc Netw, 2020, 18(10): 1312-1320. [33] 国家消化系统疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化内镜学分会,等. 中国早期结直肠癌筛查流程专家共识意见(2019,上海)[J]. 中华医学杂志,2019,99(38): 2961-2970. [34] 谭松松,杨一晖,顾凯,等. 中国不同地区人群结直肠癌筛查结肠镜顺应性的综合性分析[J]. 中华肿瘤防治杂志, 2021,28(17):1283-1289. [35] 郭晔,王洪丽,刘莹,等. 社区居民结直肠癌筛查认知及肠镜检查依从性影响分析[J]. 中国社区医师,2022,38(13): 126-128. |